Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants
2007
The
Montreal Protocolrequires limitation of the use of devices powered by
chlorofluorocarbons(CFCs), which reduce stratospheric ozone levels. Albuterol, a medication commonly used for the treatment of asthma that is delivered by
metered-dose inhalerswith CFCs as propellants, will be withdrawn from the U.S. market by December 2008. This
review articlesummarizes useful information about albuterol in
metered-dose inhalerswith non-CFC propellants and discusses associated economic issues.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
40
References
59
Citations
NaN
KQI